Everlight shifts global teleradiology stack to RadOS
The 5-year agreement will put Sirona Medical’s cloud-native platform across Everlight’s operations in 6 markets, covering PACS, reporting, worklist, archive, and AI workflows.
Everlight Radiology will move its global teleradiology operation onto Sirona Medical’s RadOS platform under a 5-year strategic partnership. The deployment will replace Everlight’s existing PACS and reporting systems across Australia, New Zealand, Ireland, the United Kingdom, the UAE, and South Africa, according to Sirona.
The agreement covers Everlight’s 800 radiologists and more than 350 hospitals over the initial term. Sirona described the deal as its first partnership outside the United States and one of the largest radiology platform agreements it has signed.
RadOS combines diagnostic viewing, reporting, PACS archive, worklist, and AI into a single cloud-native workspace. Sirona’s platform page says RadOS brings DICOM, HL7, speech, reporting, PACS, viewer, and worklist into one operating environment.
Everlight will also use Sirona’s existing Platform AI suite. The companies plan to develop agentic AI automations for clinical, administrative, and operational workflows across Everlight’s network.
The agreement gives Everlight access to Sirona’s embedded AI orchestration layer and Amplify SDK. Sirona said the tools will allow Everlight to build, deploy, and manage proprietary AI workflows across clinical and operational use cases.
Everlight will also build bespoke software and AI capabilities on top of RadOS, according to the announcement. The companies said they will collaborate on Sirona’s Agentic AI platform and other workflow features.
Companies:Sirona Medical, Everlight Radiology
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Lead-212 supply pact links Eckert & Ziegler, Thor Medical
hor Medical will initially supply Pb-212 to Eckert & Ziegler for preclinical R&D, while the companies explore broader isotope-production and radiopharmaceutical-manufacturing integration.
Aidoc creates growth post for enterprise AI push
Christopher Young will lead global expansion, partnerships, and enterprise growth after prior healthcare technology roles at BCG and Ascension.
HCA’s CHCP deal includes imaging CE provider MTMI
HCA Healthcare agreed to acquire CHCP, a Texas allied-health education provider that owns MTMI and offers programs in sonography, radiologic technology, and medical coding.
CBCT perfusion collaboration targets stroke angio suite
Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.
I-MED sale gives Jardines 215-clinic radiology network
Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.
Expected Russell addition puts Hyperfine in small-cap benchmarks
FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.
Curium approach puts Lantheus deal value near $7B
Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.
GE HealthCare to distribute NordicNeuroLab fMRI tools
The agreement covers nordicMEDiVA, nordicAktiva, selected MRI hardware, and patient comfort products across authorized global markets.
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.